Czech Republic - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Czech Republic Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases showed no change. With 8 Cases in 2019, the country was number 263 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India topped the ranking with 66,255 Cases in 2019, that is a growth of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 8.00 |
| 2018 | 12.00 |
| 2017 | 8.00 |
| 2016 | 7.00 |
| 2015 | 10.00 |
Download all data from 2005 to 2019
How does Czech Republic rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 256 |
#256
Timor-Leste
|
9 | 2019 | -25.0 % | +24.6 % | View data | |
| 263 |
#263
Czech Republic
|
8 | 2019 | -33.3 % | +0.0 % | View data | |
| 263 |
#263
Kuwait
|
8 | 2019 | +0.0 % | -2.3 % | View data | |